Takeda offers $62bn to acquire Irish rare disease company Shire
(adsbygoogle = window.adsbygoogle || []).push({}); Japanese pharma company Takeda Pharmaceutical has proposed to acquire Shire, an Ireland-based rare disease company for $62 billion after Botox-maker More...
Procter & Gamble to acquire Merck’s consumer health business for €3.4bn
P&G acquisition of Merck consumer health business : US consumer goods company Procter & Gamble (P&G) has agreed to acquire German pharma company Merck’s consumer health business in an all-cash deal More...
French pharma company Servier to acquire Shire oncology business for $2.4bn
Pharma acquisition news : French pharma company Servier Laboratories has made a $2.4 billion all-cash deal to acquire the oncology business of Irish biotech company Shire. (adsbygoogle = window.adsbygoogle More...
Sanofi announces $396m vaccine manufacturing facility in Toronto
French pharma company Sanofi has announced a new vaccine manufacturing facility in Toronto to be built with an investment of CAD500 million ($396.3 million) at the Canadian headquarters of its vaccine business unit More...
Alexion to acquire Swedish pharma company Wilson Therapeutics for $855m
Pharma acquisition news : US-based Alexion Pharmaceuticals through an all-cash deal of SEK7.1 billion ($855 million) will acquire Wilson Therapeutics, a Swedish pharma company focused on developing drugs for rare More...
GSK offloads rare disease gene therapy drugs to Orchard Therapeutics
Pharma acquisition news : British drug company GlaxoSmithKline (GSK) has agreed to transfer its rare disease gene therapy drugs to Orchard Therapeutics for an equity stake of 19.9% and a seat on the board of the More...
Novartis to buy US gene therapy company AveXis for $8.7bn
Novartis acquisition of AveXis : Swiss pharma company Novartis has struck a $8.7 billion deal to acquire US gene therapy company AveXis in a move to bolster its gene therapy and neuroscience pipeline. Novartis Acquisition More...
GSK to buy out Novartis’ stake in consumer healthcare JV for $13bn
Pharma acquisition news : GlaxoSmithKline (GSK) has agreed to buy out Swiss pharma company Novartis’ stake of 36.5% in their consumer healthcare joint venture (JV) for a price of $13 billion, just days after pulling More...
GSK, Reckitt Benckiser pull out from $20bn race to acquire Pfizer’s consumer healthcare business
Pharma acquisition news : In a blow to Pfizer’s plans to offload its consumer healthcare business for about $20 billion, both Reckitt Benckiser and now GlaxoSmithKline (GSK) have pulled out from potential acquisition More...
Danish pharma company Lundbeck to buy Parkinson’s drug developer Prexton
Pharma acquisition news : Danish pharma company Lundbeck has reached an agreement, expected to be worth around $1.1 billion, to acquire Prexton Therapeutics, a Swiss pharma company focused on Parkinson’s drug More...